Literature DB >> 7760428

Preliminary research on the p53 gene rearrangements in the evolution of chronic myelogenous leukemia to blast crisis.

J C Chen1, S M Liu, H B Fei, W L Gong.   

Abstract

DNA from 36 patients with chronic myelogenous leukemia (CML) at various clinical stages and 6 cases of acute leukemia was investigated for alterations of the p53 gene by Southern blot analysis. Rearrangements of the p53 gene were seen in 3 of 12 (25.00%) cases of blast crisis and accelerated phase (AP) of CML and in only one of 18 chronic phrase (CP), just as has been reported previously. Meanwhile, by restriction fragment length polymorphism (RFLP) analysis the Bgl II site polymorphism in the p53 gene was also found. The frequency in Chinese people detected here was 0.392, which was strikingly higher than that in some other countries (P < 0.001). These results suggested that the alterations of the p53 gene, for example, p53 rearrangements, were probably responsible for the progression of BC in some CML patients, and that the frequency of Bgl II polymorphism in the p53 gene might be related to the population distribution.

Entities:  

Mesh:

Year:  1994        PMID: 7760428     DOI: 10.1007/BF02897668

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  9 in total

1.  The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia.

Authors:  H Ahuja; M Bar-Eli; Z Arlin; S Advani; S L Allen; J Goldman; D Snyder; A Foti; M Cline
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

2.  Rearrangements in the p53 gene in Philadelphia chromosome positive chronic myelogenous leukemia.

Authors:  Z Kelman; M Prokocimer; S Peller; Y Kahn; G Rechavi; Y Manor; A Cohen; V Rotter
Journal:  Blood       Date:  1989-11-15       Impact factor: 22.113

3.  A variation in the structure of the protein-coding region of the human p53 gene.

Authors:  V L Buchman; P M Chumakov; N N Ninkina; O P Samarina; G P Georgiev
Journal:  Gene       Date:  1988-10-30       Impact factor: 3.688

4.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

5.  Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53.

Authors:  E Harlow; N M Williamson; R Ralston; D M Helfman; T E Adams
Journal:  Mol Cell Biol       Date:  1985-07       Impact factor: 4.272

6.  Structural alterations of the p53 gene in human leukemias.

Authors:  H Miwa; K Kita; H Saya; A Otsuji; M Masuya; K Nishii; N Morita; N Takakura; K Ohishi; K Nasu
Journal:  Leuk Res       Date:  1992-11       Impact factor: 3.156

7.  Transforming genes in chronic myelogenous leukemia.

Authors:  E Liu; B Hjelle; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

8.  Genomic alterations involving the c-myc proto-oncogene locus during the evolution of a case of chronic granulocytic leukaemia.

Authors:  D M McCarthy; F V Rassool; J M Goldman; S V Graham; G D Birnie
Journal:  Lancet       Date:  1984-12-15       Impact factor: 79.321

9.  Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemia.

Authors:  R Mashal; M Shtalrid; M Talpaz; H Kantarjian; L Smith; M Beran; A Cork; J Trujillo; J Gutterman; A Deisseroth
Journal:  Blood       Date:  1990-01-01       Impact factor: 22.113

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.